The US Food and Drug Administration (FDA) is consulting the public on the release of the notice intended for dietary supplements.
This notice is entitled as Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.
The notice implies the need to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information. This notice is particular on the information collection provisions of FDA's regulations regarding current good manufacturing practice (CGMP) for dietary supplements.
The public consultation for this is open until November 28, 2016.